Boardroom Alpha
Meeting calendar
RDVT · Annual meeting · Wednesday, June 3, 2026

Red Violet Inc

5 nominees · 3 ballot items.

Stockholders will vote to elect five directors to one-year terms, ratify Grant Thornton LLP as the Company’s independent registered public accounting firm for 2026, hold a non-binding advisory 'Say on Pay' to approve named executive officers’ compensation as disclosed in the proxy, and transact any other properly presented business.

Market cap
$920M
1Y TSR
+34.4%
Board grade
B-
Record date
Apr 9, 2026
Filing
DEF 14A
Meeting concluded · Jun 3, 2026

Follow how the vote landed and what changed on Red Violet Inc’s board — director track records, governance grades, and ongoing monitoring — on the Boardroom Alpha platform.

Proposals

On the ballot3

  1. 1

    Election of Directors

    ManagementBoard: FOR

    Elect five directors to serve one-year terms until the 2027 Annual Meeting or until their successors are elected and qualified.

  2. 2

    Ratification of Independent Accounting Firm

    ManagementBoard: FOR

    Ratify the appointment of Grant Thornton LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2026.

  3. 3

    Say on Pay (Non-binding Advisory Vote

    ManagementBoard: FOR

    Non-binding advisory vote to approve the compensation of the named executive officers as disclosed in the proxy statement.

    More detail

    This management proposal requests an advisory approval of the Company’s named executive officer (NEO) compensation as disclosed in the proxy statement, including the narrative, compensation tables, and related disclosures. Management seeks this non-binding vote to obtain shareholder input on pay practices and to demonstrate alignment of executive pay with company strategy and performance; the Compensation Committee will consider the vote’s outcome when setting future pay. The proxy disclosures show significant equity-based compensation (multiple RSU grants, including performance-vesting RSUs awarded in January 2026 tied to revenue and adjusted EBITDA margin targets) and discretionary cash bonuses paid in 2025, creating a mix of short- and long-term incentives intended to retain executives and align interests with stockholders. Because the vote is advisory, it will not compel immediate changes, but a negative or weak shareholder vote could prompt the Compensation Committee and Board to reassess pay structure, incentive metrics, or disclosure practices. The Board’s unanimous FOR recommendation reflects its view that the disclosed programs appropriately reward performance and support retention and alignment, and management emphasizes that the Compensation Committee periodically reviews compensation policies and risk. The proposal should be evaluated in the context of the Company’s recent pay-versus-performance disclosure, which shows increases in “compensation actually paid” alongside strong TSR and net income changes over the covered years, and the existence of a Clawback Policy and performance-based vesting conditions for certain awards. Investors considering the proposal may weigh the level and mix of pay (large RSU grants and bonuses), the presence of performance targets for some awards, and governance safeguards against excessive risk or misalignment. In short, the Say on Pay asks shareholders to endorse the current disclosed executive compensation framework; management frames it as consistent with shareholder interests and governance best practices, while shareholders dissatisfied with pay outcomes can use the advisory vote and subsequent engagement to press for changes.

Director elections

Nominees on the ballot5

Independent
Tenure on this board
2.5 yrs
Also a director at
Comscore Inc (SCOR)
Independent
Tenure on this board
7.9 yrs
Also a director at
Opko Health Inc (OPK)Cocrystal Pharma Inc (COCP)Eloxx Pharmaceuticals Inc (ELOX)Niagen Bioscience Inc (NAGE)Entera Bio Ltd (ENTX)
Independent
Tenure on this board
4.9 yrs
Also a director at
Washington Trust Bancorp Inc (WASH)
Ownership

Top institutional holders10

Latest 13F quarter
1WASATCH ADVISORS LP6.5%911,636$32M
2ASHFORD CAPITAL MANAGEMENT INC4.9%686,816$24M
3Ophir Asset Management Pty Ltd4.8%670,422$23M
4Trigran Investments, Inc.4.3%606,156$21M
5VANGUARD CAPITAL MANAGEMENT LLC3.6%512,005$18M
6BlackRock, Inc.3.0%427,306$15M
7VANGUARD PORTFOLIO MANAGEMENT LLC2.4%345,261$12M
8BlackRock, Inc.2.2%312,110$11M
9STATE STREET CORP2.2%306,241$11M
10GEODE CAPITAL MANAGEMENT, LLC1.8%260,362$9M
Filings

Recent key filings

Periodic reports
Definitive proxies
Reference

Frequently asked questions

When is the Red Violet Inc 2026 annual meeting?
Red Violet Inc (RDVT) holds its 2026 annual shareholder meeting on Wednesday, June 3, 2026.
What is the record date for the Red Violet Inc 2026 meeting?
The record date for the Red Violet Inc 2026 meeting is Thursday, April 9, 2026. Shareholders of record on or before that date are eligible to vote.
Who are the director nominees for Red Violet Inc's 2026 meeting?
The board is presenting 5 director nominees at the Red Violet Inc 2026 meeting, listed with their independence status and background.
What proposals will shareholders vote on at the Red Violet Inc 2026 meeting?
Shareholders will vote on 3 proposals at the Red Violet Inc 2026 meeting, each tagged with who proposed it and the board's recommendation.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer